Zydus Healthcare Limited
AddressZydus Healthcare Limited,
Zydus Tower, CTS No. 460/6,
Village Pahadi. Off I.B. Patel Road,
Goregaon East, Mumbai - 400063
Zydus Discovery, launched in 2013, caters to Diabetology and Cardiology therapy areas. The division launched Lipaglyn as the country’s first-ever NCE and the world’s first approved Glitazar. Lipaglyn is a unique medicine with both lipid and glucose-lowering effects in one single molecule. Its portfolio includes brands such as OLMY, Pivasta, Sugamet and Twincal for Cardiologists, Diabetologists, Endocrinologists and Physicians.
Lipaglyn is the therapy leader in the Hypertriglyceridemia market
Lipaglyn received the "Online Media Innovation - Gold Award" for blowing the whistle against ADD with International Journal of ADD at the 9th ACEF Global Customer Engagement Awards in 2020.
Lipaglyn received the Pharma Leaders Innovative Power Brand of the Year 2019 Award.